opioids

Opioid prescription limits gain supportA pharmacist organization is among the supporters of a new Medicare Part D proposal, which calls for a 7-day supply limit on opioid prescriptions.
Four pain management programs curbing the opioid epidemicFrom State-led programs to innovative pharmacist-hospital partnerships, these programs are fighting to quell the epidemic.
FDA takes tough stance on kids’ opioid cold medsFDA is taking its toughest stance yet on opioid-containing cough and cold medications for children.
An alternative treatment for OICA new study examines an alternative to current treatments of OIC in abdominoplasty patients.
Four risks healthcare executives should monitor in 2018With the right preventions in place, hospitals and healthcare executives will be well positioned to respond to these four risks in 2018.
Five key elements of successful local initiatives to combat the opioid crisisSuccessful community initiatives are creating systems of care that bridge multiple programs to provide coordinated services to individuals with substance use disorders. Here are five.
Pain control rxA recent study suggests that rhinoplasty patients may need fewer opioids than surgeons think.
FDA approves first once-monthly injection for opioid abuseSoon after FDA approved a novel device to treat opioid use disorder, FDA approved the first and only once-monthly injectable buprenorphine formulation to treat moderate to severe opioid use disorder (OUD).
How treating opioid use disorder is cost effectiveA commercial health plan analysis by axialHealthcare has interesting findings about funding opioid use disorder treatment plans.
FDA clears first opioid withdrawal deviceFDA granted a new indication to a device that can help reduce the symptoms of withdrawal from the prescription pain drugs.